<p>SATB2 is an AT-rich DNA-binding protein with a highly restricted expression pattern, primarily found in the brain, digestive tract, bone, and immune system, making it a promising target for medical research and clinical applications. Dysregulation or mutations in SATB2 have been implicated in various conditions, including cancers, isolated cleft palate, and SATB2-associated syndrome (SAS). This review aims to provide a comprehensive summary of the structure, biological functions, and potential role of SATB2 in tumor development. SATB2 influences gene regulation through epigenetic modulation, impacting various biological activities, including cell differentiation and immune responses. Recent studies have increasingly recognized its roles in tumorigenesis, including its contributions to cancer progression and metastasis. Moreover, SATB2 shows promise as a diagnostic marker and therapeutic target in oncology and bone-related disorders. Understanding its precise mechanisms in these contexts can pave the way for future advancements in therapeutic strategies. This review highlights the current state of knowledge on the roles of SATB2 and discusses its structural characteristics, biological functions, and potential implications in tumor development.</p>

错误:搜索内容不能为空,请输入英文关键词
错误:关键词超出字数限制,请精简
高级检索

Advances in research on SATB2 and its role in tumor development

  • Ge Cheng,
  • Chi Tian,
  • Waner Wang,
  • Yangyang Zhou,
  • Xiaoqing Wang,
  • Lei Zhang

摘要

SATB2 is an AT-rich DNA-binding protein with a highly restricted expression pattern, primarily found in the brain, digestive tract, bone, and immune system, making it a promising target for medical research and clinical applications. Dysregulation or mutations in SATB2 have been implicated in various conditions, including cancers, isolated cleft palate, and SATB2-associated syndrome (SAS). This review aims to provide a comprehensive summary of the structure, biological functions, and potential role of SATB2 in tumor development. SATB2 influences gene regulation through epigenetic modulation, impacting various biological activities, including cell differentiation and immune responses. Recent studies have increasingly recognized its roles in tumorigenesis, including its contributions to cancer progression and metastasis. Moreover, SATB2 shows promise as a diagnostic marker and therapeutic target in oncology and bone-related disorders. Understanding its precise mechanisms in these contexts can pave the way for future advancements in therapeutic strategies. This review highlights the current state of knowledge on the roles of SATB2 and discusses its structural characteristics, biological functions, and potential implications in tumor development.